DNAtix Successfully Transferred Craig Venter's Y Chromosome Using IBM Blockchain

Le par GlobeNewswire  |  0 commentaire(s)

Genetic Revolution Breakthrough Will Help Advance Preventive and Personalized Medicine TEL-AVIV, Israel, June 29, 2018 (GLOBE NEWSWIRE) --Digital DNAtix Ltd., the genetics blockchain company, announced the first successful transfer of a complete ...

Genetic Revolution Breakthrough Will Help Advance Preventive and Personalized Medicine

TEL-AVIV, Israel, June 29, 2018 (GLOBE NEWSWIRE) -- Digital DNAtix Ltd., the genetics blockchain company, announced the first successful transfer of a complete chromosome using blockchain technology.  With the help of IBM's Hyperledger fabric, DNAtix transferred the chromosome of genome pioneer Craig Venter, an accomplishment which further propels humanity into new discoveries in the cutting-edge frontier of genetics research and solutions.

Craig Venter, genome pioneer and world-renowned geneticist, published his full genomic data in PLOS magazine in September 2007. (1)  Venter's team used his DNA to generate an assembled diploid human genomic DNA sequencefrom both chromosomes. In the article, the authors compared Venter's sequence to reference human genome sequences to enable the study of human DNA.

"Transferring the full sequence of a virus was a challenging project but it is 'a piece of cake' compared to transferring the sequence of a full chromosome," says Ofer A. Lidsky, CEO & CTO and Co-founder of DNAtix. "We are working with genetic data and size does matter when it comes to blockchain."

IBM HYPERLEDGER
To deal with the size limitation of the current blockchain technologies, DNAtix's development team sliced Craig Venter's published DNA sequence into 19 fragments.  DNAtix used the Hyperledger Composer tool with JavaScript to transfer the 19 transactions containing the genetic code as metadata. DNAtix will release a whitepaper with an in-depth description of what the development team accomplished.  

"Our next goal is to transfer a full human genome sequence over the blockchain to enable genetic information to be shared in an anonymous and secure way," said Dr. Tal Sines, DNAtix Chief Science Officer and co-founder.

"It is symbolic that the first chromosome transferred over the blockchain is Venter's as he was one of the key players in the completion of the first human genome ever sequenced as part of the human genome project," added Dr. Sines.  "The size of the diploid human genome is 1.5 Gigabytes, so it will require compression tools to significantly reduce DNA size; a must if one desires to use blockchain technologies. As a reference the average size of a transaction over the Ethereum blockchain is approximately less than 500 bytes."

When the human genome project was completed in 2003 after 13 years, the costs for sequencing a single genome summed up to US $3B, today full genome sequencing can be completed at the price of approximately US $450 and will soon reach less than US $100. The result is that millions of people will have their genome sequenced.

ABOUT DNAtix

DNAtix, the most cutting-edge genetics and blockchain company, is building the infrastructure for the world's genetic blockchain ecosystem. An ecosystem where researchers, hospitals, developers, clinicians and others will develop the next generation of decentralized genetics applications and health management solutions.  DNAtix is also delivering a direct-to-consumer platform that offers anonymous and encrypted genome sequencing and genetic services, including digitized DNA analysis, storage and transfer. The DNAtix genetics ecosystem is a place where consumers and the industry can meet to share genetic data in a more transparent, accessible, applicable and secured manner. DNAtix is developing the future ecosystem for genetics. A blockchain-based, cutting-edge new, innovative approach to DNA research. DNAtix is the first company to successfully transfer a genetic sequence over the Ethereum Blockchain, and now the first to transfer a complete chromosome. www.dnatix.com

  1. PLoS Biol. 2007 Sep 4;5(10):e254. The diploid genome sequence of an individual human.  Levy S1, Sutton G, Ng PC, Feuk L, Halpern AL, Walenz BP, Axelrod N, Huang J, Kirkness EF, Denisov G, Lin Y, MacDonald JR, Pang AW, Shago M, Stockwell TB, Tsiamouri A, Bafna V, Bansal V, Kravitz SA, Busam DA, Beeson KY, McIntosh TC, Remington KA, Abril JF, Gill J, Borman J, Rogers YH, Frazier ME, Scherer SW, Strausberg RL, Venter JC.

Media Contact: 
Heidi Groshelle
Groshelle Communications
heidi@groshelle.com
415.307.1380




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: DNAtix via Globenewswire

Source(s) : DNAtix

Complément d'information
Soyez le premier à commenter ce communiqué :
Poster un commentaire
Vos commentaires
Gagnez chaque mois un abonnement Premium avec GNT : Inscrivez-vous !
Suivre les commentaires
Poster un commentaire
Anonyme